Interdisciplinary Clinical And Health Ethic Research And Training To Improve Outcomes In Immunosuppressed Haematology Pa
Funder
National Health and Medical Research Council
Funding Amount
$2,000,000.00
Summary
The Centre will improve Australia's capacity to combat and prevent life-threatening infections, and reduce adverse social outcomes, in high-risk children and adults with heavily suppressed immune systems. Infections cause most preventable disease and death in these patients. We will establish multidisciplinary training programmes in clinical and ethics research and build on our expertise in infectious diseases and microbiology, diagnostics, haematology, immunisation, health informatics and bioet ....The Centre will improve Australia's capacity to combat and prevent life-threatening infections, and reduce adverse social outcomes, in high-risk children and adults with heavily suppressed immune systems. Infections cause most preventable disease and death in these patients. We will establish multidisciplinary training programmes in clinical and ethics research and build on our expertise in infectious diseases and microbiology, diagnostics, haematology, immunisation, health informatics and bioethics to improve patient outcomes. These outcomes will be translatable to other high-risk patients such as those with cancer and the critically ill.Read moreRead less
Bioreactors for manufacture of human platelets. Blood cell transfusion is a critical part of medicine that is supported by volunteer donors. Unfortunately, the demand for blood cells for transfusion far outstrips supply and therefore new strategies are required for manufacture of blood cells. This project will lead to the development of technology for manufacture of human platelets from stem cells. The systems devised will be applicable to a broad range of other blood cell types.